Dual effect of erythropoietin on liver p
โ
Franklin Greif; Ziv Ben-Ari; Rasim Taya; Orit Pappo; Efrat Kurtzwald; Yelena Che
๐
Article
๐
2010
๐
John Wiley and Sons
๐
English
โ 500 KB
The only currently offered curative option for many patients with primary or secondary liver tumors is the resection of hepatic tumors. The aim of this study was to evaluate the role of recombinant human erythropoietin (rhEPO) in liver protection and regeneration after subtotal hepatectomy in rats.